Advertisement

Organisation › Details
Progen Biotechnik GmbH
Founded in 1983 as one of the first biotechnology companies in Germany, PROGEN Biotechnik GmbH is now an established manufacturer and supplier of research antibodies and immunological test systems for the global life science community. PROGEN’s antibodies are among the most published antibodies in biomedical and cell biology literature. Building on its core-competency in immunochemistry, the ISO 13485 certified company has expanded its collaborations and business in recent years to access new research markets with innovative immunological products for protein detection, quantification and purification. Special focus lies on the development of ELISA test systems for the determination of adeno-associated virus (AAV) titers in gene therapeutic research and development. PROGEN places great value on premium quality and is breaking new ground in product validation to meet the key demand of the research community for high quality, reliable immunochemicals. Since 2012, Heidelberg-based PROGEN has been a 100% subsidiary of R-Biopharm AG. *
![]() |
Start | 1983-01-01 established |
Group | R-Biopharm (Group) | |
Predecessor | DKFZ (German Cancer Research Center, GCRC) | |
![]() |
Industry | research reagent |
Industry 2 | research antibody | |
![]() |
Person | Betts, Katja (R-Biopharm 201904– Managing Director Commercial at Progen Biotechnik GmbH joined 2016) |
Person 2 | Lander, Maik (R-Biopharm 201904– Managing Director Development + Manufacturing at Progen Biotechnik GmbH joined 2016) | |
![]() |
Region | Heidelberg |
Country | Germany | |
Street | 30 Maaßstr. | |
City | 69123 Heidelberg | |
Tel | +49-6221-8278-0 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | B: 11 to 50 (2018-10-23) |
* Document for »About Section«: Progen Biotechnik GmbH. (5/15/19). "Press Release: Progen Biotechnik GmbH Now With New Joint Leadership". Heidelberg. | ||
Record changed: 2025-03-16 |
Advertisement

More documents for R-Biopharm (Group)
- [1] Robert Bosch GmbH. (4/18/24). "Press Release: Additional Partnership in Medical Technology – Bosch and R-Biopharm to Strengthen Vivalytic Analysis platform". Darmstadt, Gerlingen & Waiblingen....
- [2] Leon-Nanodrugs GmbH. (7/18/23). "Press Release: Leon-Nanodrugs Appoints Dr. Hans Frickel as Chief Executive Officer". Munich....
- [3] R-Biopharm AG. (7/1/19). "Press Release: Distribution of the New Innovative Molecular Diagnostics Platform Vivalytic Starts". Darmstadt....
- [4] Progen Biotechnik GmbH. (5/15/19). "Press Release: Progen Biotechnik GmbH Now With New Joint Leadership". Heidelberg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top